Arindam Ray

Excited to give an oral presentation of my work at the @ASH_hematology Annual Meeting in Orlando on Dec 6th. Happy to have received #AbstractAchievementAward Looking forward to a great meeting! #ASH25 #ASHAwards #NKCell #Lymsm #Leusm #ImmunOnc #Hematology

Fascinating paper in @Nature today about how 🧬 variant impacting cyclin D3 alters malaria infectivity of red cells! nature.com/articles/s4158…, nature.com/articles/d4158… ... Follows up on some of our original studies from over 14 years ago: genesdev.cshlp.org/content/26/18/…

Honored to be selected as this year’s March of Dimes Prize awardee. Grateful for the incredible work my lab has done over the years. I embraced developmental biology when I started my lab and am excited to see its principles translate to patients. marchofdimes.org/about/news/ren….

Check out this important advance in mitochondrial 🧬 lineage tracing by @tGaoTeng and @chenweng1991 from our group, in collaboration with @JswLab 👇👇

Excited to share our latest study published in @CellCellPress !! We uncovered that a single oncolytic virus injection can ignite deep, persistent T cell immunity in glioblastoma, lasting months to years. sciencedirect.com/science/articl…

Congrats to @SetPointMed for this landmark study in @NatureMedicine that led to FDA approval for targeting the vagus nerve inflammatory reflex to treat rheumatoid arthritis. rdcu.be/eVUwr.

Newly uncovered missing link in cellular cleanup can help develop therapeutic strategies for Alzheimer’s, Parkinson pib.gov.in/PressReleasePa… Research team led by Prof. @RaviManjithaya @jncasr @IndiaDST Research publication: doi.org/10.1073/pnas.2…

For researchers in #PancreaticCancer (and those in cancer research in general), this series of murine Kras;p53 cancer cell lines of varying immunogenicity created by @BenStanger01 are an invaluable resource. These are also of confirmed genetic background. kerafast.com/productgroup/8…

Feeling great to have presented my work at #ASH25. What an amazing conference this has been! Thank you for the wonderful opportunity! Looking forward to the ASH meeting next year and hope to showcase again our work from @DanaFarber #Hematology #leusm #lymsm #ashawards #NKCell

Congratulations @InamdarManeesha Ma’am for the new endeavor! My Best Wishes!

My 1st PhD student @UjjayitaC 's 1st preprint is out now! We investigate how hematopoiesis is remodelled during cancer cachexia! Brilliant work done by Ujjayita & lab members! This study opens up new avenues for our lab 😊 @biopatrika biorxiv.org/content/10.110…

Excited to finally see this @DanaFarber_GU (@eddy_saad @MarcMachaalani) collaboration with @kaelin_lab @broadinstitute led by @RemailehAbu published in @NatureMedicine 1) PTHLH->HIF2 transcriptional target in ccRCC. 2) Increased PTHLH is necessary/sufficient for the induction of hypercalcemia & cachexia in preclinical models. 3) Two HIF2 inhibitors improved hypercalcemia and cachexia in patients with ccRCC. => Clinically, this can explain at least in part weight gain on HIF2 inh => Future, can PTHrP-targeted interventions (directly through anti-PTHrP therapies or indirectly through the HIF2–PTHrP axis) block the onset of cachexia? Link: nature.com/articles/s4159…

Inhibitory PD-1 axis maintains high-avidity stem-like CD8+ T cells @Nature #Germain @NIAIDNews nature.com/articles/s4158…

If you have not read this moving and courageous essay from Tatiana Schlossberg in the @NewYorker, please check it out. You may be wondering why inv(3) leukemia is so deadly? Here is a brief 🧵 (1/n)

"After 16 years in academia, I’ve become more selective about collaboration. It remains a joy and a blessing, but I’ve also learned how quickly 'we' can turn wicked." #ScienceWorkingLife. scim.ag/47QSNdF

New data show radiotherapy can induce amphiregulin, reprogram myeloid cells, and support distant tumour growth. Understanding this may help us design better treatment paths for patients. @Nature @OncoAlert nature.com/articles/s4158…

Joint profiling of gene expression and chromatin accessibility in pancreatic lymph nodes and spleens in human type 1 diabetes | ⁦@SciImmunology⁩ ⁦@golnaz_v⁩ ⁦@UPenn_I3H⁩ science.org/doi/10.1126/sc…

“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.” Genes-> Medicine @NatureMedicine nature.com/articles/s4159…

Happy to share a pre-print of my PhD work! We show that OCIAD2 promotes epithelial-to-mesenchymal transition during mesendoderm specification of human embryonic stem cells. @InamdarManeesha @jncasr @DBT_inStem #hPSCs #stemcells

Excited to share our study @CellCellPress introducing a novel class of macrophage-targeted immunocytokines (MiTEs) that engage myeloid, T and NK cells to boost anti-tumor immunity in solid tumors. Led by @MVLocquenghien, @PascaleZwicky & @CuriousKX (1/16) cell.com/cell/abstract/…